[
    "{\"step_by_step_thinking\": \"To determine if marimastat is effective for small-cell lung cancer, we need to analyze the relevant documents. Document [0] reports the results of a prospective, randomized, double-blind, placebo-controlled trial of marimastat in patients with small-cell lung cancer. The trial found that treatment with marimastat after induction therapy did not result in improved survival and had a negative impact on quality of life. Document [2] also mentions that pivotal phase III trials in small-cell lung cancer were discontinued because marimastat failed to show superior efficacy over standard chemotherapy or placebo. Based on these findings, the answer is B. no, marimastat is not effective for small-cell lung cancer.\", \"answer_choice\": \"B\"}"
]